US Tuberculosis Diagnosis and Treatment Market Trend, CAGR Status, Growth, Analysis and Forecast to 2025

US tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around -0.2% during the forecast period. Though, tuberculosis (TB) is a preventable as well as curable disease, too many people in US still suffers from it. Centre of Disease Control and Prevention (CDC) plays a crucial role in TB elimination in the country. It works with state and local partners toward the goal of TB elimination. Moreover, it collects TB surveillance data to track national progress towards elimination and inform TB prevention and control activities. The US Agency for International Development (USAID) is the lead implementing agency for the country's global TB efforts. All US TB efforts have been coordinated under the international working group of the Federal Tuberculosis Task Force.

Get Sample Copy of US Tuberculosis Diagnosis and Treatment Market at: https://www.omrglobal.com/request-sample/us-tuberculosis-diagnosis-treatment-market

The key players that are active in the market include Abbott Laboratories, Akonni Biosystems, Inc., Alere Inc., Becton, Dickinson and Co., Cepheid, Inc., Hologic, Inc., Johnson & Johnson, Novartis AG, Pfizer Inc. and Thermo Fisher Scientific.

Additionally, the US partners with international institutions for supporting global TB funding mechanisms. Moreover, US are the largest donor to the Global Fund and it has committed around $5.9 billion in funding for TB programs globally. Furthermore, it is one of the largest donors to the Global Drug Facility which is a mechanism of the Stop TB Partnership that provides grants to countries for TB drugs. Their key partners are WHO and the Stop TB Partnership. Moreover, the country supports TB activities through several other agencies including CDC, NIH and OGAC & DoD.

For More Information, get A full report of US Tuberculosis Diagnosis and Treatment Market is available at: https://www.omrglobal.com/industry-reports/us-tuberculosis-diagnosis-treatment-market

US tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing.

Market Segmentation

Tuberculosis Diagnosis and Treatment Market by Drugs Type

o First Line Drugs
o Second Line Drugs

Tuberculosis Diagnosis and Treatment Market by Diagnosis

o Laboratory Testing
o Nucleic Acid Amplification Test
o Mantoux Test
o Radiography
o Drug Susceptibility Testing

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/us-tuberculosis-diagnosis-treatment-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.